Bio-IT World 2008
Rapid RNAi Informatics Development with PointDragonTM
The ability to rapidly implement and evolve laboratory workflows in an environment of changing platform tech-nologies is a constant challenge. We will show how at Sirna Therapeutics (a wholly owned subsidiary of Merck & Co., Inc.) we have addressed this using the PointDragon Platform to develop a custom LIMS implementation that integrates sample tracking and annotation, data translation and long-range planning and resource management in a single application. The system provides the flexibility to support Sirnas discovery pipeline using standardized business rules for decision-making, while allowing ready access to underlying data for long-term process analysis. We will describe lessons learned and comparisons to our experience with other LIMS solutions.
Alex Birch, LIMS Developer, Sirna Therapeutics (a wholly owned subsidiary of Merck & Co., Inc.)